Machine Learning

With backing from AstraZeneca and Pfizer, Beijing’s Syneron Bio is using its AI-driven platform to develop novel drugs for cancer and chronic illness.

A publicly listed venture builder reports explosive growth and a radical new strategy: using a video game to democratize venture capital for everyone.

Tech billionaire and commercial astronaut Jared Isaacman is the new NASA chief. Can his entrepreneurial vision and private space experience reshape the agency?

A new AI accelerator promises to cut the complex Adobe Experience Platform migration from weeks to days, reshaping digital transformation timelines.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

WhiteFiber lands a 10-year, 40 MW anchor deal with AI provider Nscale, validating its high-density strategy and fueling North Carolina's tech boom.

Facing a critical cash shortfall, Cue Biopharma turns to the market, betting its promising cancer and autoimmune pipeline can win over investors.

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

Two titans of boat rentals unite, forming a marketplace to reshape water adventure tourism with AI, massive scale, and a focus on the blue economy.

A Minnesota startup has secured major funding to advance its bioelectronic device aimed at the brain's waste clearance system for treating CNS disorders.

With a fresh $1.5M, Katalist aims to automate video production from script to screen. But can its AI truly replace traditional workflows and empower storytellers?

A new standing wheelchair module offers unprecedented height, blending advanced engineering with profound health and social benefits for users.

eXp Realty's new partnership with Land id gives agents advanced mapping tools, promising to reshape property analysis and set new industry standards.

European FinTech Multitude AG unveils its 2026 financial calendar, offering investors a clear roadmap amid strong growth and evolving market dynamics.

The AI defense firm's stock surged after announcing a share repurchase, a move reflecting deep internal confidence amid a booming defense-tech market.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

RELEX Solutions' strategic acquisition of Ida aims to revolutionize fresh food management, promising less waste, higher sales, and a smarter supply chain.

A new partnership between DoControl and Sentra promises to turn data insights into automated security, closing a critical gap in SaaS data protection.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Newly public AI firm Fusemachines unveils an ambitious 2026 growth plan, but faces significant financial hurdles and deep investor skepticism.